Free CME from PeerView


Pulmonary/Respiratory Medicine CME

Credits: 1.0 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
Alexander Drilon, MD
September 02, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Controlling Moderate to Severe Asthma Across the Lifespan in an Ever-Evolving Treatment Landscape: How Much Do You Know?
Wanda Phipatanakul, MD, MS
August 25, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing the Underlying Inflammation of Non–Cystic Fibrosis Bronchiectasis: Exploring Novel Treatments to Change Disease Course for Patients and Improve Quality of Life
Cedric "Jamie" Rutland, MD
August 23, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Confronting the Challenges of Nontuberculous Mycobacterial Lung Disease: Expert Strategies for Reducing Diagnostic Delays and Improving Adherence to Guideline-Based Treatment
Julie V. Philley, MD / Kevin Winthrop, MD, MPH
August 09, 2022
Credits: 1.0 CME / MOC
Johns Hopkins University School of Medicine
Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Shmuel Shoham, MD
July 08, 2022
Credits: 1.75 CME / MOC
PVI, PeerView Institute for Medical Education
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy From Advanced to Early Disease
David P. Carbone, MD, PhD
June 28, 2022
Credits: 0.5 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
The Power of Interprofessional Teams in SSc-ILD: From Diagnosis Through Management
Lisa H. Lancaster, MD
June 21, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
Stephen V. Liu, MD
June 05, 2022
Jacob Sands, MD
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
Jacob Sands, MD
June 04, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
The Future of Severe Asthma Treatment Is Here: Expert Insights on the Rationale for Targeting Epithelial Alarmins
Reynold A. Panettieri, Jr., MD
June 02, 2022
Credits: 0.75 CME / NCPD / CPE
PVI, PeerView Institute for Medical Education
Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity
Zev A. Wainberg, MD
May 31, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Airway Inflammation Isn’t the Only Problem: Shining a Light on the Role of Airway Hyper-Responsiveness in Severe Asthma
Jonathan Corren, MD
May 26, 2022
Nasser Altorki, MD
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC
Nasser Altorki, MD  /  Jonathan D. Spicer, MD, PhD, FRCSC
May 15, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium
Professor Andrew Menzies-Gow
May 04, 2022
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies
Linda Ahn, MSN, ANP-BC, AOCNP
April 28, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
Jacob Sands, MD
April 27, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC
Mark A. Socinski, MD
April 20, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
How I Think, How I Treat—Assessing, Managing, and Engaging Patients With Uncontrolled, Moderate to Severe Asthma: Comparing Approaches With Experts Around the World
Michael E. Wechsler, MD
April 12, 2022
Credits: 1.5 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD
March 23, 2022
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD
March 22, 2022
Purvi S. Parikh, MD, FACP, FACAAI/Cedric Jamie Rutland, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Taking It From the Top: Targeting a New Approach to Controlling Severe Asthma
Purvi S. Parikh, MD, FACP, FACAAI / Cedric "Jamie" Rutland, MD
March 17, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
Nasser Altorki, MD / Jonathan D. Spicer, MD, PhD, FRCSC
February 22, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
Pasi A. Jänne, MD, PhD
February 22, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Bringing Precision Oncology to Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way: What Thoracic Surgeons Need to Know and Do
Boris Sepesi, MD / Tina Cascone, MD, PhD
February 21, 2022
Stephen V. Liu, MD
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Visual Exploration of the Possibilities for Macrocyclic TKIs in Treatment-Naive and Pretreated Fusion-Positive NSCLC and Other Tumors
Stephen V. Liu, MD
February 18, 2022
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Expert Perspectives on Improving Early Recognition of Eosinophilic Esophagitis and Examining the Potential Clinical Utility of Emerging Targeted Therapy
Amal H. Assa'ad, MD
December 14, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
David R. Jones, MD
November 19, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView